Biotech Company That Botched Vaccines Faces Investor Revolt

NYT > Top Stories Chris HambyIn the latest shareholder lawsuit, a pension fund accused executives at Emergent BioSolutions of insider trading. The company, under investigation by Congress, has halted manufacturing of Covid-19 vaccines at its Baltimore factory at regulators’ request. July 06, 2021 at 09:00AM https://ift.tt/2VfZqER